Prothrombin A19911G polymorphism and the risk of venous thromboembolism
暂无分享,去创建一个
P. Mannucci | P. Mannucci | A. Tosetto | I. Martinelli | C. Legnani | T. Battaglioli | P. Mannucci | L. Sottile | R. Ghiotto
[1] N. von Ahsen,et al. The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system. , 2004, Blood.
[2] J. Heit,et al. Risk factors for venous thromboembolism. , 2003, Clinics in chest medicine.
[3] J. Corral,et al. Prothrombin A19911G and G20210A polymorphisms' role in thrombosis , 2002, British journal of haematology.
[4] E. Pollak,et al. The G20210A mutation does not affect the stability of prothrombin mRNA in vivo. , 2002, Blood.
[5] A. Carter,et al. Prothrombin G20210A is a Bifunctional Gene Polymorphism , 2002, Thrombosis and Haemostasis.
[6] Matthias W. Hentze,et al. Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia , 2001, Nature Genetics.
[7] F. Rosendaal,et al. Polymorphisms in the Prothrombin Gene and their Association with Plasma Prothrombin Levels , 2001, Thrombosis and Haemostasis.
[8] L. Almasy,et al. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. , 2000, Blood.
[9] G. Leone,et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. , 1998, Blood.
[10] S. Béguin,et al. Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[11] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[12] A. Tosetto,et al. The VITA Project: Population-based Distributions of Protein C, Antithrombin III, Heparin-cofactor II and Plasminogen -Relationship with Physiological Variables and Establishment of Reference Ranges , 1996, Thrombosis and Haemostasis.
[13] A. Tosetto,et al. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. , 1996, American journal of epidemiology.
[14] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[15] B. Dahlbäck,et al. Resistance to activated protein C as a basis for venous thrombosis. , 1994, The New England journal of medicine.
[16] B. Dahlbäck,et al. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Bertina,et al. Spectrophotometric Assays of Prothrombin in Plasma of Patients Using Oral Anticoagulants , 1979, Thrombosis and Haemostasis.
[18] I. Peake. International Society on Thrombosis and Haemostasis , 1974, Thrombosis and Haemostasis.